The role of non-antibody-based approaches to immunomodulation in multiple myeloma

The role of non-antibody-based approaches to immunomodulation in multiple myeloma

The role of non-antibody-based approaches to immunomodulation in multiple myeloma

In this video, Sagar Lonial, MD, Winship Cancer Institute of Emory University, Atlanta, GA, comments on the role of non-antibody-based approaches in the treatment of multiple myeloma, highlighting the growing importance of IMiDs and CELMoDs.This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

Leave a Reply

Your email address will not be published.